PCN106 Capecitabine Plus Oxaliplatin (CAPOX) Versus Fluorouracil/Leucovorin plus Oxaliplatin (FOLFOX) in Stage III Colon Cancer: A Cost-Minimization Analysis Based on Real World Costs in the Netherlands
| Verfasser: | |
|---|---|
| Dokumenttyp: | Artikel |
| Erscheinungsdatum: | 2011 |
| Reihe/Periodikum: | Value in Health ; volume 14, issue 7, page A453 ; ISSN 1098-3015 |
| Verlag/Hrsg.: |
Elsevier BV
|
| Schlagwörter: | Public Health / Environmental and Occupational Health / Health Policy |
| Sprache: | Englisch |
| Permalink: | https://search.fid-benelux.de/Record/base-26800107 |
| Datenquelle: | BASE; Originalkatalog |
| Powered By: | BASE |
| Link(s) : | http://dx.doi.org/10.1016/j.jval.2011.08.1207 |
